Coherus Biosciences reported $35.23M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Aerie Pharmaceuticals AERI:US USD 6.93M 3.19M
Akebia Therapeutics AKBA:US USD 29.68M 19.2M
Alnylam Pharmaceuticals ALNY:US USD 41.12M 308K
Amarin AMRN:US USD 23.94M 11.87M
Amgen AMGN:US USD 1.59B 78M
Baxter International BAX:US USD 2.63B 337M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Coherus Biosciences CHRS:US USD 35.23M 23.96M
Eli Lilly And LLY:US USD 1.58B 148.6M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Fujifilm 4901:JP JPY 437.81B 66.4B
Gilead Sciences GILD:US USD 1.4B 47M
Horizon Pharma HZNP:US USD 234.13M 3.92M
Merk MRK:US USD 3.43B 715M
Myriad Genetics MYGN:US USD 50.4M 700K
Pacira Pharmaceuticals PCRX:US USD 50.68M 51K
Perrigo Ordinary Shares PRGO:US USD 737.3M 12.3M
Pfizer PFE:US USD 6.09B 2.58B
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Revance Therapeutics RVNC:US USD 10.74M 1.21M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M
Zoetis ZTS:US USD 606M 14M